Intensity Therapeutics Provides Mid-Year Update Highlighting Late-Stage Development Programs and Strategic Partnering Opportunities for INT230-6

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/23/2026

1. USO
2. META
3. NVDA
4. SPY
5. DCOY
6. MSFT
7. VKTX
8. PRGS
9. DGX
10. IONQ

Go back to Intensity Therapeutics Provides Mid-Year Update Highlighting Late-Stage Development Programs and Strategic Partnering Opportunities for INT230-6
(NASDAQ: INTS) Delayed: 4.01 -0.01 (0.25%)
Previous Close $4.02    52 Week High $ 
Open $4.01    52 Week Low $ 
Day High $4.11    P/E N/A 
Day Low $3.89    EPS $ 
Volume 14,776